Description

* Cagrilintide

Long-acting amylin receptor agonist peptide

Studied in research for its effects on:

• Appetite suppression & satiety signaling

• Delayed gastric emptying

• Reduction in food intake

• Synergistic effects with GLP-1 agonists

• Metabolic regulation & body weight control

Potent amylin analogue with prolonged half-life, widely used in preclinical studies (often in combination with GLP-1 agonists like semaglutide) to investigate dual-hormone approaches to obesity and metabolic disease.

For research use only. Not for human consumption.